US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0610

-0.0058-8.68%

Volume:25.41K

Turnover:1.40K

Market Cap:- -

PE:- -

High:0.0621

Open:0.0572

Low:0.0527

Close:0.0668

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.revivapharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RVPHW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVPHW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPHW\",,,,,undefined,":{"symbol":"RVPHW","market":"US","secType":"WAR","nameCN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","latestPrice":0.061,"timestamp":1746028626296,"preClose":0.0668,"halted":0,"volume":25406,"delay":0,"strike":11.5,"lastTradingDate":1766638800000,"nameEN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.0058,"latestTime":"04-30 12:06:08 EDT","open":0.0572,"high":0.0621,"low":0.0527,"amount":1399.0596404799999,"amplitude":0.140719,"askPrice":0.066,"askSize":100,"bidPrice":0.0525,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0668,"preHourTrading":{"tag":"盘前","latestPrice":0.053,"preClose":0.0668,"latestTime":"08:43 EDT","volume":333,"amount":24.54870006,"timestamp":1746017021572},"postHourTrading":{"tag":"盘后","latestPrice":0.0668,"preClose":0.0668,"latestTime":"18:12 EDT","volume":28,"amount":1.8265,"timestamp":1745964761718},"volumeRatio":1.994339,"lotSize":1,"type":1,"expireDate":1766638800000,"ul":"RVPH","ulStockBrief":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":0.8522,"timestamp":1746028849884,"preClose":0.877,"halted":0,"volume":129446,"delay":0}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPHW\",,,,,undefined,":{"symbol":"RVPHW","floatShares":0,"roa":"-23.19%","roe":"-53.85%","lyrEps":0,"volumeRatio":1.994339,"shares":0,"dividePrice":0,"high":0.0621,"amplitude":0.140719,"preClose":0.0668,"low":0.0527,"week52Low":0.0226,"pbRate":"0.00","week52High":0.78,"institutionHeld":0,"latestPrice":0.061,"committee":-0.818182,"eps":0,"divideRate":0,"volume":25406,"delay":0,"ttmEps":0,"open":0.0572,"prevYearClose":0.1644,"prevWeekClose":0.0617,"prevMonthClose":0.0549,"prevQuarterClose":0.0549,"fiveDayClose":0.0635,"twentyDayClose":0.035,"sixtyDayClose":0.19},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.revivapharma.com","stockEarnings":[{"period":"1week","weight":0.052},{"period":"1month","weight":0.237},{"period":"3month","weight":-0.5547},{"period":"6month","weight":-0.332},{"period":"1year","weight":-0.8702},{"period":"ytd","weight":-0.5937}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.203101},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.00832},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.216573},{"month":4,"riseRate":0.571429,"avgChangeRate":0.119599},{"month":5,"riseRate":0.5,"avgChangeRate":0.198451},{"month":6,"riseRate":0.5,"avgChangeRate":0.202005},{"month":7,"riseRate":0,"avgChangeRate":-0.255197},{"month":8,"riseRate":0.5,"avgChangeRate":0.167803},{"month":9,"riseRate":0.833333,"avgChangeRate":0.11375},{"month":10,"riseRate":0.166667,"avgChangeRate":0.205487},{"month":11,"riseRate":0.571429,"avgChangeRate":0.33309},{"month":12,"riseRate":0.571429,"avgChangeRate":0.087235}],"exchange":"NASDAQ","name":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","nameEN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RVPHW\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVPHW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVPHW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVPHW\",market:\"US\",delay:false,,,undefined,":{}}}